These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3439972)

  • 1. [Side effects and risks in cytapheresis donors].
    Borberg H; Gaczkowski A; Kadar J; Böhm R
    Beitr Infusionther Klin Ernahr; 1987; 18():192-8. PubMed ID: 3439972
    [No Abstract]   [Full Text] [Related]  

  • 2. [The safety of apparative cytapheresis].
    Böhm R; Borberg H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():18-27. PubMed ID: 3679527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications related to equipment and technique.
    Klein HG; McCurdy PR; Braine HG; MacPherson JL; Dowling RN
    J Clin Apher; 1983; 1(3):190-5. PubMed ID: 6546057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and safety practices in hemapheresis procedures.
    Huestis DW
    Arch Pathol Lab Med; 1989 Mar; 113(3):273-8. PubMed ID: 2645853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Side effects in plasma exchange (PE) and therapeutic cytapheresis (TCP)].
    Höcker P; Wagner A; Hofer M; Spreng S; Pittermann E
    Beitr Infusionther Klin Ernahr; 1987; 18():234-7. PubMed ID: 3439981
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of different methods of blood separation in performing plasma- and cytapheresis].
    Ryzhko VV; Gorodetskiĭ VM; Rogova EM
    Ter Arkh; 1988; 60(5):85-8. PubMed ID: 3175936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial contamination of cellular blood components: risks, sources and control.
    Blajchman MA
    Vox Sang; 2004 Jul; 87 Suppl1():98-103. PubMed ID: 15200616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Implementation of apparative hemapheresis for collecting blood component stores. Recommendations of the Hemapheresis Commission of the German Society of Transfusion Medicine and Immunohematology].
    Kretschmer V; Borberg H; Giannitsis D; Kamanabroo D; Mempel W; Müller V; Müller N; Neumeyer H
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():57-64. PubMed ID: 3679531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects of thrombocytapheresis and leukocytapheresis in healthy donors].
    Höcker P; Wagner A; Puffer G; Michl U
    Beitr Infusionther Klin Ernahr; 1987; 18():205-9. PubMed ID: 3439974
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of adverse effects during hemapheresis.
    Strauss RG
    J Clin Apher; 1996; 11(3):160-4. PubMed ID: 8915821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can (should) apheresis supplant whole blood collection?
    Ciavarella D
    Transfus Sci; 1992 Apr; 13(2):201-5. PubMed ID: 10148126
    [No Abstract]   [Full Text] [Related]  

  • 12. [Complications in therapeutic cytapheresis and plasma exchange treatments].
    Ullrich H; Wiebecke D; Hohe R; Gunzer U; Mansouri-Taleghani B
    Beitr Infusionther Klin Ernahr; 1987; 18():241-3. PubMed ID: 3439983
    [No Abstract]   [Full Text] [Related]  

  • 13. Side-effects of cytapheresis with cell separators.
    Höcker P; Wagner A
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():31-5. PubMed ID: 3679528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedside processing.
    Krause KP
    Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
    [No Abstract]   [Full Text] [Related]  

  • 15. Maximizing blood component donations.
    Fuller MJ
    Vox Sang; 2000; 78 Suppl 2():47-9. PubMed ID: 10938926
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of apheresis donation.
    Sniecinski IJ
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():52-6. PubMed ID: 3679530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of donating multiple products in a single apheresis collection: are we expecting too much?
    Strauss RG
    J Clin Apher; 2003; 18(3):135-40. PubMed ID: 14569607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of blood component preparation with blood cell separators.
    Borberg H; Böhm R
    Infusionstherapie; 1989 Aug; 16 Suppl 2():21-9; discussion 28-9. PubMed ID: 2583841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocytapheresis with the new PLT-30 collection chamber in the CS 3000 Plus cell separator].
    Moog R; Müller N
    Beitr Infusionsther Transfusionsmed; 1994; 32():323-4. PubMed ID: 9480118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hazards of apheresis and the U.K. approach to guidelines.
    Robinson A
    Transfus Sci; 1990; 11(3-4):305-8. PubMed ID: 10149530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.